Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of Inactivated EV71 Vaccine in Infants and Children
NCT01421121Phase 2Completed
- Sponsor
- Sinovac Biotech Ltd.
- Start
- Jun 2011
- Primary completion
- Sep 2011
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of enterovirus 71 vaccine (vero cell), inactivated in enterovirus 71 infection, HIV-associated central nervous system involvement (HAND), sponsored by Sinovac Biotech Ltd.. Started Jun 2011; status: completed.
02
Drugs
enterovirus 71 vaccine (vero cell), inactivated
03
Conditions
enterovirus 71 infectionHIV-associated central nervous system involvement (HAND)
Beyond the preview
Go deeper on NCT01421121.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01421121.